Robotic Anatomic Segmentectomy of the Lung: Technical Aspects and Initial Results

Pardolesi, Alessandro; Park, Bernard J.; Petrella, Francesco; Borri, Alessandro; Gasparri, Roberto; Veronesi, Giulia

doi:10.1016/j.athoracsur.2012.04.086

Cited by 108 publications

(83 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pardolesi et al reported the safety and feasibility of robotic segmentectomy, including a 17.6% morbidity rate. 24) On the other hand, Paul et al reported that robotic lobectomy was significantly higher risk factor of iatrogenic complication including vessel injury than thoracoscopic lobectomy from the Nationwide Inpatient Sample. 25)…”

Section: Perioperative Outcomesmentioning

confidence: 99%

Robotic Surgery for Thoracic Disease

Yamashita

Yoshida

Iwasaki

2016

ATCS

View full text Add to dashboard Cite

Section: Perioperative Outcomesmentioning

confidence: 99%

Robotic Surgery for Thoracic Disease

Yamashita

Yoshida

Iwasaki

2016

ATCS

View full text Add to dashboard Cite

“…The safety and the feasibility of robotic anatomic lung resection have been shown in several case series (6,12,15), robot is gaining in popularity as proponents claim additional benefits of improved ergonomics, three-dimensional optics, and 7-degree endowrist capabilities allowing more thorough lymph node dissection and simplifying operative procedure. However, limited and conflicting perioperative outcomes have been published by different case cohorts (8)(9)(10)(11).…”

Section: Discussionmentioning

confidence: 99%

“…We perform robotic lobectomies based on the 4-incision technique established by Veronesi and associates (6), and segmentectomies refer to the 4-incision technique introduced by Pardolesi and colleagues (12). As for thoracoscopic lobectomy and segmentectomy, we use conventional 3-incision technique, a 4 cm incision at the anterior axillary line at the 4th or 5th intercostal space, a 30-degree thoracoscope was introduced via the 7th intercostal space in the midaxillary line, another 10 mm accessory incision was made at the tip of the scapula, pulmonary vessels and bronchus were transected with endoscopic staplers, while the specimen was removed by a plastic bag for pathological examination.…”

Section: Methodsmentioning

confidence: 99%

Comparison of robotic and video-assisted thoracic surgery for lung cancer: a propensity-matched analysis

Bao¹,

Zhang²,

Yang³

et al. 2016

J. Thorac. Dis.

View full text Add to dashboard Cite

Background: Reports of comparison between robotic and thoracoscopic surgery for lung cancer are limited, we aimed to compare the perioperative outcomes of robotic and thoracoscopic anatomic pulmonary resection for lung cancer. 50.3±37.9 mL, P=0.531), morbidity rates (42.0% vs. 30.4%, P=0.157) were similar between the robotics and thoracoscopy. However, robotics was associated with higher cost ($12,067±1,610 vs. $8,328±1,004, P<0.001), and longer operative time (136±40 vs. 111±28 min, P<0.001). Conclusions: Robotics seems to have higher hospital costs and longer operative time, without superior advantages in morbidity rates and oncologic efficiency. Further prospective randomized clinical trials were needed to validate both of its short-and long-term oncologic efficiency.

show abstract

“…This was followed by robotic anatomic segmentectomies [75]. The robotic approach involves articulated robotic arms together with a mini-thoracotomy.…”

Section: Surgery For Early Stage Lung Cancer (Stage I and Ii)mentioning

confidence: 99%

Surgery for nonsmall cell lung cancer

Lang-Lazdunski

2013

European Respiratory Review

View full text Add to dashboard Cite

Surgery remains the best curative option in patients with early stage lung cancer (stage I and II). Developments in minimally invasive techniques now allow surgeons to perform lung resections on elderly patients, patients with poor pulmonary function or significant cardiopulmonary comorbidities. New techniques, such as stereotactic radiotherapy and ablative procedures, are being evaluated in early-stage lung cancer and may represent an alternative to surgery in patients unfit for lung resection. Perioperative mortality rates have dropped significantly at most institutions in the past two decades and complications are managed more efficiently. Progress in imaging and staging techniques have helped cut futile thoracotomy rates and offer patients the most adequate treatment options. Large randomised trials have helped clarify the role of neoadjuvant, induction and adjuvant chemotherapy, as well as radiotherapy. Surgery remains an essential step in the multimodality therapy of selected patients with advanced-stage lung cancer (stage III and IV). Interventional and endoscopic techniques have reduced the role of surgery in the diagnosis and staging of nonsmall cell lung cancer, but surgery remains an important tool in the palliation of advanced-stage lung cancer. Large national/international surgical databases have been developed and predictive risk-models for surgical mortality/morbidity published by learned surgical societies. Nonetheless, lung cancer overall survival rates remain deceptively low and it is hoped that early detection/screening, better understanding of tumour biology and development of biomarkers, and development of efficient targeted therapies will help improve the prognosis of lung cancer patients in the next decade. @ERSpublications Despite progress in surgical techniques, radiotherapy techniques and targeted therapy, lung cancer prognosis remains poor

show abstract

Robotic Anatomic Segmentectomy of the Lung: Technical Aspects and Initial Results

Cited by 108 publications

References 23 publications

Robotic Surgery for Thoracic Disease

Robotic Surgery for Thoracic Disease

Comparison of robotic and video-assisted thoracic surgery for lung cancer: a propensity-matched analysis

Surgery for nonsmall cell lung cancer

Contact Info

Product

Resources

About